Table 1.
Baseline characteristics of involved participants
| Characteristics | Missing data n (%) | Total (n = 1, 478) | Non-CAD (n = 419) | ACS (n = 1, 059) | P |
|---|---|---|---|---|---|
| Demographic data | |||||
| Age, years | 0 (0.00) | 33 (30–35) | 33 (30–35) | 33 (30–35) | 0.270 |
| Male [n(%)] | 0 (0.00) | 1, 373 (92.90) | 368 (87.83) | 1005 (94.90) | < 0.001 |
| Height, cm | 161 (10.89) | 172.64 ± 6.79 | 172.68 ± 7.41 | 172.62 ± 6.51 | 0.875 |
| Weight, kg | 161 (10.89) | 82.95 ± 15.32 | 80.22 ± 17.05 | 84.12 ± 14.37 | < 0.001 |
| BMI, kg/m2 | 161 (10.89) | 27.73 ± 4.42 | 26.74 ± 4.84 | 28.15 ± 4.15 | < 0.001 |
| Vital signs | |||||
| SBP, mmHg | 1 (0.10) | 124.56 ± 16.05 | 125.12 ± 14.48 | 124.34 ± 16.64 | 0.399 |
| DBP, mmHg | 1 (0.10) | 77.96 ± 12.37 | 77.95 ± 10.97 | 77.97 ± 12.89 | 0.977 |
| HR, bpm | 1 (0.10) | 75.74 ± 12.28 | 75.38 ± 12.55 | 75.88 ± 12.17 | 0.480 |
| Life styles | |||||
| Smoker, n(%) | 0 (0.00) | 984 (66.58) | 232 (55.37) | 752 (71.01) | < 0.001 |
| Drinker, n(%) | 0 (0.00) | 358 (26.05) | 107 (25.54) | 251 (23.70) | 0.459 |
| Past history | |||||
| EH, n(%) | 0 (0.00) | 491 (33.22) | 102 (24.34) | 389 (36.73) | < 0.001 |
| DM, n(%) | 0 (0.00) | 133 (9.00) | 22 (5.25) | 111 (10.48) | 0.001 |
| Dyslipidaemia, n(%) | 0 (0.00) | 152 (10.28) | 47 (11.22) | 105 (9.92) | 0.449 |
| Prior lipid-lowing treatment, n(%) | 0 (0.00) | 236 (15.97) | 21 (5.01) | 215 (20.30) | < 0.001 |
| Laboratory parameters | |||||
| WBC, ×109/L | 27 (1.83) | 8.29 ± 3.07 | 7.13 ± 1.88 | 8.70 ± 3.29 | < 0.001 |
| RBC, × 1012/L | 17 (1.15) | 4.99 ± 0.45 | 4.98 ± 0.51 | 5.00 ± 0.42 | 0.453 |
| HGB, g/L | 17 (1.15) | 152.32 ± 14.54 | 152.03 ± 16.42 | 152.43 ± 13.78 | 0.629 |
| PLT, ×109/L | 17 (1.15) | 239.64 ± 61.74 | 224.70 ± 54.48 | 245.56 ± 63.46 | < 0.001 |
| TP, g/L | 16 (1.08) | 69.65 ± 5.60 | 70.51 ± 5.55 | 69.31 ± 5.58 | < 0.001 |
| PALB, g/L | 27 (1.83) | 0.28 ± 0.06 | 0.29 ± 0.06 | 0.27 ± 0.06 | < 0.001 |
| BUN, g/L | 4 (0.27) | 4.723 ± 1.59 | 5.07 ± 1.53 | 4.59 ± 1.59 | < 0.001 |
| CR, mmol/L | 4 (0.27) | 76.99 ± 16.41 | 77.42 ± 16.98 | 76.82 ± 16.18 | 0.532 |
| FBG, mmol/L | 4 (0.27) | 5.76 ± 1.76 | 5.34 ± 1.21 | 5.93 ± 1.91 | < 0.001 |
| GA, % | 558 (37.75) | 13.33 ± 3.41 | 12.77 ± 1.77 | 13.53 ± 3.79 | 0.003 |
| HbA1C, % | 564 (38.16) | 6.10 ± 4.38 | 6.18 ± 8.79 | 6.08 ± 1.45 | 0.788 |
| Lipid profiles | 0 (0.00) | ||||
| TC, mmol/L | 4.58 ± 1.35 | 4.36 ± 1.07 | 4.67 ± 1.44 | < 0.001 | |
| TG, mmol/L | 1.82 (1.26–2.78) | 1.58 (1.07–2.40) | 1.95 (1.33–2.89) | < 0.001 | |
| HDL-C, mmol/L | 0.94 ± 0.22 | 1.03 ± 0.25 | 0.91 ± 0.21 | < 0.001 | |
| LDL-C, mmol/L | 2.89 ± 1.13 | 2.68 ± 0.85 | 2.97 ± 1.21 | < 0.001 | |
| AIP | 0.31 ± 0.32 | 0.21 ± 0.33 | 0.35 ± 0.30 | < 0.001 | |
| CAG characteristics | 0 (0.00) | ||||
| One-vessel, n(%) | 519 (35.12) | ||||
| Two-vessel, n(%) | 244 (16.51) | ||||
| Three-vessel, n(%) | 192 (12.99) | ||||
| GS | 32 (14–62.75) | ||||
CAD coronary artery disease, ACS acute coronary syndrome, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, DM diabetes mellitus, EH essential hypertension, WBC white blood cell, RBC red blood cell, HGB hemoglobin, PLT platelet, TP total protein, PALB pre-albumin, BUN blood urea nitrogen, CR creatinine, FBG fasting blood glucose, GA glycated albumin, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, AIP atherogenic index of plasma, CAG coronary angiography, GS Gensini score
Bold values indicate statistical significance